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Cell entryAdenovirus (Ad) membrane penetration during cell entry is poorly understood. Here we show that
antibodies which neutralize the membrane lytic activity of the Ad capsid protein VI interfere with Ad
endosomal membrane penetration. In vitro studies using a peptide corresponding to an N-terminal
amphipathic α-helix of protein VI (VI-Φ), as well as other truncated forms of protein VI suggest that VI-Φ is
largely responsible for protein VI binding to and lysing of membranes. Additional studies suggest that VI-Φ
lies nearly parallel to the membrane surface. Protein VI fragments membranes and induces highly curved
structures. Further studies suggest that protein VI induces positive membrane curvature. These data support
a model in which protein VI binds membranes, inducing positive curvature strain which ultimately leads to
membrane fragmentation. These results agree with previous observations of Ad membrane permeabilization
during cell entry and provide an initial mechanistic description of a nonenveloped virus membrane lytic
protein.gy and Immunology, Loyola
Rm. 3812, Maywood, IL 60153,
).
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Cell membranes are a major obstacle to viral infection of host cells.
Unlike enveloped viruses, which fuse the viral envelope with cellular
membranes to gain access to intracellular sites of replication,
nonenveloped viruses must employ alternative mechanisms to cross
this barrier (Tsai, 2007). Our understanding of how nonenveloped
viruses penetrate cellular membranes lags signiﬁcantly behind that of
analogous events occurring during enveloped virus cell entry.
Adenoviruses are a family of nonenveloped dsDNA virus, which
penetrate endosomal membranes during cell entry to gain access to
the cytoplasm. However, the mechanisms involved in this event have
yet to be fully deﬁned.
To enter cells, Ads ﬁrst bind to a primary attachment receptor via
high afﬁnity interactions between the virus ﬁber protein and the cell
surface receptor (Chroboczek et al., 1995). For subgroup A, C, E and F,
this receptor is the coxsackievirus and adenovirus receptor (Roelvink
et al., 1998). For subgroup B and D viruses, this receptor has been
found to be CD46, sialic acid or CD80/CD86 (Sakurai et al., 2007). After
attachment, secondary engagement of αv integrins by the RGD motif
of the viral penton base protein triggers clathrin mediated endocy-
tosis of virions (Nemerow, 2000).For subgroup C viruses, disassembly of the viral capsid is initiated
very soon after attachment, with the ﬁber reportedly released from
the virion at the cell surface (Greber et al., 1993; Nakano et al., 2000).
Endocytosis results in further disassembly of the Ad capsid proteins as
additional proteins are shed from the virus (Greber et al., 1993).
Uncoating correlates with acidiﬁcation of the endosomal compart-
ment (Svensson, 1985; Greber et al., 1993) and is enhanced by
interactions between the penton base and αv integrins (Wickham
et al., 1993, 1994). Studies employing a temperature sensitive mutant
Ad2ts1, which possesses a hyperstable capsid when produced at the
nonpermissive temperature due to lack of proteolytic capsid matu-
ration, have demonstrated that, although this virus can attach and
trigger endocytosis, it's failure to uncoat in endosomes prevents
endosomal escape (Hannan et al., 1983; Greber et al., 1996).
Additionally, while entry of wt Ad2 virions leads to eventual
degradation of the interior capsid protein VI (pVI), by 2 h post-
infection, the precursor form of pVI present in the ts1 virions is not
degraded during cell entry presumably because it is not released from
the virion (Greber et al., 1993, 1996).
The exact mechanisms of Ad endosomal membrane penetration
remain to be determined. While initial studies had implicated the
penton base in the permeabilization of cellular membranes (Seth et al.,
1984, 1985; Seth, 1994), many of these studies were conducted prior to
our understanding of the role for the penton base interactions with αv
integrins. Perhaps the greatest evidence against a role for the penton
base in direct permeabilization of endosomal membranes is the
observation that incubation of cells with puriﬁed penton base at a
concentration of 1 mg/ml did not directly permeabilize cell membranes
12 Rapid Communicationbut could actually prevent Ad2 virions from releasing [3]H-choline from
cells (Wickham et al., 1993, 1994). In contrast, one of the proteins
released from the viral capsid during disassembly within endosomes,
pVI, was recently found to possess N95% of the in vitromembrane lytic
activity of the capsid (Wiethoff et al., 2005). This in vitromembrane lytic
activity is pH independent, is possessed by both the precursor and the
mature form of pVI, and is dependent upon an N-terminal predicted
amphipathic α-helix.
Currently little structural information is available regarding pVI.
Present at 342–369 copies per virion (van Oostrum and Burnett, 1985;
Lehmberg et al., 1999), pVI is expressed as a preprotein. This
preprotein, facilitates nuclear accumulation of the major capsid
protein, hexon, by mediating hexon import through nuclear pore
complexes during virus assembly (Wodrich et al., 2003). Additionally,
the C-terminus of pre-pVI serves as an allosteric activator of the virally
encoded 23K cysteine protease which cleaves several capsid protein
precursors during capsid maturation (Mangel et al., 1996). A tentative
location of pVI underneath the 60 peripentonal hexons was originally
suggested based on electron cryomicroscopy studies (Stewart et al.,
1993). More recent studies using genetic and molecular modeling
have suggested that pVI interactions with hexon occur in a large
interior cavity of the hexon (Wodrich et al., 2003). This location was
further supported by higher resolution structures determined by
electron cryomicroscopy (Saban et al., 2005, 2006; Silvestry et al.,
2009). These later studies have also suggested that density within the
internal cavity of each of the 240 hexon proteins of the Ad capsid may
correspond to pVI. Further studies should eventually provide a more
deﬁnitive description of the location of pVI within Ad virions.
Our current studies demonstrate that pVI membrane lytic activity
is required for efﬁcient endosomal membrane penetration during Ad
cell entry. Mechanistic studies indicate that the N-terminal amphi-
pathic α helix is critical for pVI binding to and disrupting endosomal
membrane. This helix alone is sufﬁcient to mediate membrane
disruption. The helix binds to lipid membranes, lying nearly parallel
to the surface of the lipid bilayer. Disruption of liposomal membranes
by pVI does not appear to involve the formation of pores with
diameters less than 100 Å but rather a gross reorganization of the lipid
bilayer resulting from the induction of positive membrane curvature.
These studies support a role for pVI in Ad endosomal membrane
penetration during cell entry, and represent a signiﬁcant advance in
our understanding of the mechanisms of nonenveloped virus
penetration of cell membranes.
Results
Protein VI is involved in Ad endosomal membrane penetration
Previous work has shown that Ad pVI possesses all of the in vitro
membrane lytic activity observed for Ad5 virions (Wiethoff et al.,
2005). To determine whether pVI plays a role in adenovirus
endosomal membrane penetration, we generated rabbit polyclonal
antibodies raised against recombinant pre-pVI. These antibodies were
afﬁnity-puriﬁed against recombinant Ad5 pVI coupled to cyanogen
bromide agarose beads. To demonstrate the ability of αpVI to prevent
pVI disruption of cellular membranes, recombinant pVI was added to
Hela cells in the presence of preimmune IgG or αpVI and the
percentage of cells which stained positive with the membrane
impermeable DNA intercalating dye, propidium iodide, were deter-
mined by ﬂuorescence microscopy (Fig. 1A). Incubation of cells with
puriﬁed pVI in the presence of excess αpVI lead to a N90% decrease in
propidium iodide positive cells compared to cells treated with pVI in
the presence of excess preimmune IgG.
Since polyclonal rabbitαpVI can inhibit pVImembrane lytic activity,
we next assessed the ability of αpVI to block Ad5 infection. Since pVI is
not exposed on the capsid exterior (Everitt et al., 1975; Saban et al.,
2006; Silvestry et al., 2009) but becomes accessible upon virusuncoating in endosomes (Greber et al., 1993, 1996), endosomal
compartments were saturated with antibody by incubating Hela cells
with either preimmune IgG or αpVI for 6 h prior to infection with a
replication defective E1, E3-deleted Ad, possessing an EGFP expression
cassette (Ad5gfp). The percentage of gfp positive cells was then
determined 24 h post-infection. A∼2 and 5-fold decrease in gfp positive
cellswas observedwhen cellswere incubatedwith the 0.4 and 1 mg/ml
αpVI respectively compared to cells incubated with preimmune IgG,
suggesting that pVI plays a role in virus entry (Fig. 1B). To rule out an
effect ofαpVI onAd5gfp cell binding,we also addedantibodies to cells at
the same time as Ad5gfp. Under these conditions, we did not observe a
difference between Ad5gfp infectivity in cells incubated with pre-
immune IgG orαpVI (not shown). These data suggest that the decrease
observed in Fig. 1B is not due to αpVI interfering with Ad5 cell binding.
To determine if this decreased transduction by Ad5gfp is due to αpVI
antibodies inhibiting pVI disruption of endosomal membranes and,
therefore, inhibiting virus release into cytosol, we looked at the ability of
αpVI to prevent Ad5gfp-mediated cytosolic translocation of a mem-
brane impermeable ribosomal toxin, saporin. Endosomal compartments
were again saturatedwith antibodies asdescribed before, and cellswere
infectedwith Ad5gfp in the continued presence of antibody. At the time
of infection, these cells were also treated with saporin, a membrane
impermeable toxin, whose translocation into the cytosol is facilitated by
cointernalization with the virus in endosomes, and subsequent virus
mediated membrane disruption. Once in the cytosol, the toxin inhibits
protein synthesis, ultimately resulting in cell death which is quantiﬁed
viaMTT assay. Preincubation with 1 mg/mlαpVI increased the amount
of Ad5 necessary to induce a 50% decrease in cell viability by 5-fold
compare topreimmune IgG, indicating that pVI antibodies decrease Ad5
mediated cytosolic translocation of saporin (Fig. 1C). Thus, αpVI is able
to prevent Ad membrane disruption and is also able to prevent
endosomal membrane penetration by Ad5gfp.
The N-terminal amphipathic α-helix is important for pVI
membrane lytic activity
Currently there is no structural information regarding pVI.
Secondary structure predictions suggest that the N-terminal 80
residues of mature pVI (residues 34–114) are predicted to form
a stable α-helical domain (Fig. 2A) (Wiethoff et al., 2005). The
C-terminal domain is mostly disordered and contains a mixture
of α-helical and β-structures. The membrane lytic activity of pVI
was previously shown to be independent of pH and is strongly
dependent on the presence of 20 residues at the N-terminus that are
predicted to form an amphipathic α-helix (Wiethoff et al., 2005). To
examine the importance of speciﬁc pVI domains for the observed
membrane lytic activity, we initially used the heterologous over-
expression of truncated versions of pVI in E. coli. Puriﬁed protein was
used to assess the ability of various truncations in pVI to facilitate
membrane disruption by monitoring the ability of puriﬁed forms of the
proteins to mediate the release of an entrapped ﬂuorophore (SulfoB)
from the interior of model membranes in the form of liposomes
(Fig. 2B).Wild type pVI caused a dose dependent release of SulfoB from
liposomes. The truncated 80 residue N-terminal domain (VI114Δ)
possesses identical membrane lytic activity compared to the full length
protein suggesting that the C-terminal 125 residues of pVI contribute
signiﬁcantly less to the in vitro membrane lytic activity. Equivalent
membrane lytic activity was also observed for a 24 residue pep-
tide corresponding to residues 34–54 and possessing an additional
c-terminal tetralysine tag to enhance aqueous solubility sug-
gesting that this helix was sufﬁcient for in vitro membrane
disruption. Truncation of pVI by removing residues 34–54 compris-
ing the N-terminal amphipathic α-helix (VIΔ54) greatly reduces the
membrane lytic activity of the protein, requiring ∼400-fold higher
concentrations of protein to elicit similar SulfoB release as the
mature form of the protein. Since equivalent amounts of the
Fig. 1. αpVI antibodies inhibit protein VI membrane permeabilization and decrease adenovirus infectivity. A) Hela cells were treated with puriﬁed pVI in the presence of either
preimmune IgG or afﬁnity-puriﬁed αpVI and the percentage of cell nuclei stained with the membrane impermeable dye, propidium iodide were quantiﬁed by ﬂuorescence
microscopy. B) Hela cells were preincubated with preimmune IgG (black bars) or afﬁnity-puriﬁed anti-pVI (white bars) for 6 h before infection with Ad5gfp in the continued
presence of the antibody. Relative infectivity was calculated by determining the percentage of GFP positive cells 20 h post-infection. C) Hela cells preincubated with antibodies as
described above were infected with increasing MOIs of Ad5gfp in the presence of the ribosomal toxin saporin. Saporin mediated cytotoxicity was quantiﬁed by MTT assay 24 h post-
infection and % cell viability determined. Preimmune IgG (●), anti-pVI (○). Error bars represent the standard error of the mean for a minimum of 3 replicates.
13Rapid Communicationirrelevant protein, bovine serum albumin, do not induce signiﬁcant
SulfoB release, our data with the truncated VIΔ54 protein suggest
that additional residues within pVI may also be involved in
membrane interactions.
To further assess the role of the amphipathic α-helix in pVI
membrane disruption, we examined the relative afﬁnity of each
protein construct and peptide for the same liposomalmembranes. The
binding of pVI to liposomes was assessed using changes in intrinsicFig. 2. Adenovirus protein VI disruption of and binding to liposomes. A) The predicted seco
(lines) secondary structures are displayed. Recombinant forms of pre-pVI, pVI, VIΔ54, VI114
membrane lytic activity was measured by quantifying the release of SulfoB from liposo
C) Membrane binding of the different pVI constructs. Increasing lipid concentrations were a
the fractional saturation (θ) of pVI binding capacity as described in the Materials and metho
■ Protein VI ◆ VI34–54 ▲ VIΔ54 ○ VI114Δ. △ BSA.tryptophan ﬂuorescence upon association to membranes. By assum-
ing that the relative change in tryptophan ﬂuorescence upon binding
liposomes was directly related to the amount of pVI bound to
membranes, binding isotherms were generated and the fractional
saturation of binding sites was plotted versus increasing lipid
concentrations (Fig. 2C). While pVI, VI114Δ and VI34–54 all possessed
similar afﬁnities as evidenced by dissociation constants between 2–
4 μM, VIΔ54 membrane afﬁnity was ∼600-fold lower. These resultsndary structure of pVI with α-helices (cylinders) β-sheets (arrows) and unstructured
Δ and VI34–54 were used in studies of membrane binding and permeabilization. B) pVI
mes after treatment with increasing concentrations of the different pVI constructs.
dded to pVI constructs and changes in tryptophan ﬂuorescence were used to determine
ds. Error bars represent the standard error of the mean for a minimum of 3 replicates.
14 Rapid Communicationsuggest that the N-terminal amphiphathic α-helix is important for
membrane binding. Additionally, there is a strong correlation
between the afﬁnity of pVI for membranes and the in vitromembrane
lytic activity.
Orientation of the pVI N-terminal amphipathic α-helix on
model membranes
How this N-terminal amphipathic α-helix of pVI is oriented on the
membrane upon binding is also of interest and could provide
considerable insight into the mechanism of membrane disruption.
Using the well documented distance-dependent quenching of
tryptophan ﬂuorescence by bromine atoms (Markello et al., 1985),
we determined the depth of the conserved W37, W41, and W59
residues in lipid membranes containing brominated lipid which have
bromine atoms covalently attached at speciﬁc positions on the lipid
alkyl chains. Single tryptophan mutants of the 80 residue VI114Δ
construct were made by mutating 2 out of the 3 tryptophans to
phenylalanine since phenylalanine residues do not possess the
ﬂuorescent properties of tryptophan but have membrane binding
properties most similar to tryptophan (Wimley and White, 1996).
These mutants were shown to possess identical membrane lytic
activity as wild type protein and they possessed similar secondary
structure content as assessed by circular dichroism spectroscopy
(Figs. S1 and S2). Of note, VI114Δ possessed 87%α-helical content and
13% random coil in agreement with secondary structure predictions.
Using this approach W37 and W41 were found to be 9.6 and 10.6 Å
from the center of the bilayer by parallax analysis (Table 1). The
distance from the center of the bilayer Zcf, was determined both via
parallax and distribution analyses (Chattopadhyay and London, 1987;
Ladokhin, 1997). Interestingly,W59, which is outside the predicted N-
terminal amphipathic helix was also found to interact with the
membrane, being 10.3 Å from the center of the bilayer. As a control for
the assay, we found that the single tryptophan of melittin was 10.9 Å
from the center of the bilayer, which is in good agreement with
previously published reports which position this tryptophan 10.8 Å
from the bilayer center (Ghosh et al., 1997). Since W37 and W41
would be ∼6 Å apart in an α-helix, yet they are positioned at depths
which differ by only ∼1 Å in themembrane, it is likely that this helix is
positioned in an oblique orientation relative to the membrane surface
and does not traverse the apolar region of the lipid bilayer. The angle
between W37 and W41 would correspond to 10° from the bilayer–
water interface. A model for the orientation of this helix on
membranes is shown in Fig. 3.
Protein VI mediates membrane disruption by inducing positive
membrane curvature
Since the above data suggest a superﬁcial oblique orientation for
the pVI N-terminal α-helix which is a key determinant of pVI
membrane lytic activity, we considered that pVI may be inducing
curvature stress in membranes leading to membrane disruption. To
examine this possibility, we ﬁrst determined the effects of pVI onTable 1
Depth of protein VI tryptophan residue penetration into lipid bilayers. The distances of
W37, W41 and W59 from the center of the lipid bilayer (Zcf) were calculated by
distance-dependent quenching of tryptophan ﬂuorescence. The Zcf values were
calculated for each tryptophan residue as described in the Materials and methods
section using Parallax and Distribution analyses.
Zcf (Å´)
Parallax DA
W37 9.6±0.2 9.7±0.2
W41 10.6±0.3 10.6±0.3
W59 10.3±0.5 10.5±0.7membrane morphology using giant ﬂuorescent lipid vesicles (GLV).
The GLVmembranes were labeled with 5 mol% ﬂuoresceinylated lipid
and observed by epiﬂuorescence microscopy. Vesicles appear 5–
50 μm in diameter and this morphology is unchanged upon addition
of PBS (Fig. 4, top). Vesicles incubated with VIΔ54 (1:100 protein:
lipid) appeared similar to PBS treated vesicles (Fig. 4, middle). Upon
addition of protein VI to GLVs at a protein:lipid molar ratio of 1:100,
the vesicles were fragmented into smaller structures with a greatly
increased radius of curvature (Fig. 4, bottom). Of note, reorganization
of lipid membranes into tubular structures (arrows) appears to result
from pVI addition. This data supports the hypothesis that pVI
fragments membranes by inducing signiﬁcant membrane curvature.
The observation that pVI fragments membranes by inducing
membrane curvature is in line with one proposed mechanism of
membrane disruption by cationic antimicrobial peptides (Brogden,
2005). These peptides have been shown to fragment membranes
either by inducing positive membrane curvature or negative mem-
brane curvature. To determine whether pVI induces positive or
negative membrane curvature, we prepared liposomes entrapping
SulfoB and containing increasing amounts of lipids which have a
preference to adopt either positively (lysophosphatidylcholine,
lysoPC) or negatively (phosphatidylethanolamine PE) curved mem-
branes. If pVI membrane lytic activity involves the induction of
positive membrane curvature, then we would expect the presence of
lysoPC to enhance pVI membrane lytic activity while PE would inhibit
pVImembrane lytic activity. Sincewe observed exactly these effects of
lysoPC and PE on pVI membrane lytic activity (Fig. 5), we conclude
that pVI disrupts membranes by inducing positive membrane
curvature. In further support of this observation, the primary
sequence of the N-terminal amphipathic α-helix of pVI suggests
that it ﬁts recently identiﬁed criteria for helices which induce or
associate with positively curved membranes (Drin et al., 2007). These
helices typically possess a relatively small hydrophobic surface, few if
any charged residues, and possess a hydrophilic surface which is
composed mostly of short hydrophilic amino acids such as serine,
threonine or glycine.
Although results above demonstrate that pVI can fragment lipid
membranes by inducing positive membrane curvature, they do not
rule out the possibility that at lower ratios of pVI to lipid, pore
structures are formed. In fact, the toroidal pore model for peptide
induced membrane permeabilization involves amphipathic α-helix-
induced positive curvature in membrane lipids such that the pore
channel is lined both by peptide and lipid headgroups (Epand and
Vogel, 1999; Brogden, 2005). To determine whether pVI induced size
selective pores in lipid membranes we compared the release of the
0.5 kDa SulfoB and 70 kDa FITC-dextran from liposomes incubated
with increasing amounts of pVI at an overall lower ratio of protein to
lipid (Fig. 6). Previous studies have demonstrated that 70 kDa FITC-
dextran has a hydrodynamic radius of 100 Å (Bohrer et al., 1979) and
is unable to diffuse through membrane channels less than 50 Å in
diameter (Ladokhin et al., 1997). If a size selective pore were formed
at these lower ratios of pVI to lipid, then we would expect that a
greater release of sulfoB compared to FITC-dextran would be
observed. Since we observe comparable degrees of ﬂuorophore
release from vesicles by pVI, we conclude that pVI does not form
pores capable of discriminating between 6 and 100 Å diameter
molecules.
Discussion
Like most viruses, Ads have conserved genomic size by encoding
multiple functions in a single protein which may work during
different phases of the viral life cycle. Adenovirus pVI functions
during later stages of infection by facilitating virus assembly (Hannan
et al., 1983;Webster and Kemp, 1993; Ding et al., 1996;Wodrich et al.,
2003). Amino acids between residues 48–74 and 233–239 of pVI
Fig. 3.Model for VI34–54 amphipathicα-helix orientation in lipid bilayer. Residues 34–54 of Ad5 protein VI weremodeled as an alpha-helix using swisspdb viewer and overlaid on the
three dimensional structure of POPC lipids in the Lcα phase (POPC128a.pdb, downloaded from http://people.ucalgary.ca/∼tieleman/download.html) such that the distance of the
center of W37 and W41 (green) were positioned at the distance from the center of the bilayer (Zcf) presented in Table 1 (indicated by white arrows).
15Rapid Communicationmediate hexon binding and facilitate hexon nuclear import where
capsid assembly occurs (Matthews and Russell, 1994, 1995; Wodrich
et al., 2003). The C-terminal 11 residues of pVI function late in the
virus life cycle by activating the adenoviral 23K cysteine protease
which cleaves several capsid proteins to trigger capsid maturation
(Hannan et al., 1983; Webster and Kemp, 1993; Ding et al., 1996).
Most recently a role for pVI during cell entry has been proposed
(Wiethoff et al., 2005). Our current data support a role for pVI in
adenovirus escape from endosomes during cell entry. Furthermore,
themajor determinant of this activity of pVI appears to be a 20 residue
putative N-terminal amphipathic helix.
It is well documented that adenovirus penetration of cell
membranes occurs from within endosomal compartments (Brown
and Burlingham, 1973; Svensson and Persson, 1984; Greber et al.,
1993). To penetrate endosomal membranes, the adenovirus capsid
must partially uncoat; a process that begins at the cell surfacewith the
loss of the ﬁber protein and is enhanced through interactions with αv
integrins (Wickham et al., 1994; Nakano et al., 2000). Within
endosomes, acidiﬁcation facilitates further uncoating (Svensson and
Persson, 1984; Greber et al., 1993; Wiethoff et al., 2005). Previous
studies of the membrane lytic activity of Ad capsids demonstrated
that (Svensson and Persson, 1984; Greber et al., 1993; Wiethoff et al.,
2005) membrane lytic activity is attributed to pVI (Wiethoff et al.,
2005). These observations correlate with the inability of Ad2ts1,
which possesses a hyperstable capsid and does not release pre-pVI
upon endocytosis, to escape from endosomes (Greber et al., 1993,
1996). Additionally, capsid stabilization by defensins inhibits pVI
release from the capsid and prevents Ad endosomal membrane
penetration (Smith and Nemerow, 2008). Here we provide additional
support for a role of pVI in endosomal membrane penetration by
preventing this activity through the use of antibodies capable of
neutralizing pVI membrane lytic activity. Our studies demonstrate
that antibodies against protein VI must be present at relatively high
concentrations to achieve signiﬁcant inhibition of Ad cell entry and
endosomal escape. However, since pVI is not exposed on the virus
exterior but is released from the virus upon uncoating in endosomes,
this observation is not unexpected. Similar neutralization of reovirus
membrane penetration and poliovirus membrane penetration has
been reported using antibodies against membrane disrupting pro-
teins, μ1 and VP4, respectively. In these cases, however, pretreatment
of reovirus with trypsin to generate ISVPs and expose μ1 (Hooper and
Fields, 1996) or preincubation of poliovirus with VP4 antibodies at
37 °C for 1 h prior to infection (Li et al., 1994) was required to exposeμ1 and VP4 for neutralization. Such prior exposure of pVI would
require the dissociation of the receptor binding ﬁber and penton base
proteins from the capsid, an event which would prevent Ad5 infection
by itself. Thus, while higher concentrations of αpVI can neutralize
adenovirus infection, it seems implausible that these antibodies
would impact infections, in vivo. This idea is supported by the lack of
previous reports identifying neutralizing antibodies against pVI in
clinical specimens. Nevertheless, neutralization of adenovirus infec-
tion by αpVI by blocking endosomal escape demonstrates a role for
pVI in virus cell entry.
Currently, the molecular mechanisms of cell membrane disruption
by capsid proteins of nonenveloped viruses is still poorly deﬁned.
Membrane destabilizing sequences from rotavirus (Dowling et al.,
2000; Tihova et al., 2001; Golantsova et al., 2004), reovirus (Danthi
et al., 2008a,b; Ivanovic et al., 2008), papillomaviruses (Kamper et al.,
2006), picornaviruses (Prchla et al., 1995; Tosteson and Chow, 1997)
and nodaviruses (Bong et al., 2000; Maia et al., 2006; Banerjee et al.,
2009) have been reported, although the exact mechanisms of how
they disrupt membranes are still under investigation. Our studies
suggest that the N-terminal amphipathic helix of pVI binds to
membrane surfaces in an oblique orientation and that this helix is
sufﬁcient to lyse membranes in vitro. Removal of this helix leads to a
severe reduction in the membrane binding and membrane lytic
capacity of pVI suggesting that this helix is the major determinant of
pVI membrane lytic activity.
While reovirus μ1 and picornavirus VP1/VP4 are suggested to form
pores to disrupt cell membranes, it has been proposed that Ad5 pVI
disrupts membranes by fragmentation (Wiethoff et al., 2005). The
oblique orientation of the N-terminal amphipathic helix observed in
these studies is more in line with membrane fragmentation than it is
with pore formation (Epand and Vogel, 1999; Epand and Epand,
2000). This more severe reorganization of membranes via pVI could
facilitate the translocation of a 90 nm diameter capsid across
endosomal membranes. Additionally, Ad has been shown to facilitate
the cytosolic translocation of other viruses such as a 25 nm diameter
Minute Virus of Mice further supporting a gross reorganization of
endosomal membranes by Ad (Farr et al., 2005). Our results suggest
that pVI disruption of membranes does not likely involve the
formation of pores with diameters less than 100 Å and it is unlikely
that a 22 kDa or perhaps a 20 residue peptide would be able to induce
stable pores with larger diameters. Our results using epiﬂuorescence
microscopy to examine the ability of pVI to reorganize ﬂuorescently
labeled giant lipid vesicles conﬁrms previous observations that pVI
Fig. 4. Protein VI fragmentation of giant lipids vesicles. Fluorescein-DHPE labeled giant
lipid vesicles were incubated with PBS (TOP), VIΔ54 (MIDDLE) or protein VI (BOTTOM)
for 15 min before visualization by epiﬂuorescence microscopy. Protein–lipid ratios
were 1:100 (mol/mol). Arrows indicate tubular lipid structures formed in the presence
of protein VI.
Fig. 5. Positive curvature promoting lipids enhance protein VI membrane lytic activity.
POPC:POPS (75:25 mol%) (●) liposomes entrapping SulfoB and in which some POPC
was replaced with 5 (Δ) or 10 (▲) mol% lysoPC or 15 (□) or 25 (■) mol% of POPE were
incubated with increasing amounts of protein VI. The %SulfoB released was determined
as described in the Materials and methods. Error bars represent the standard error of
the mean for a minimum of 3 replicates.
Fig. 6. Protein VI does not induce size selective permeability of membranes. POPC:POPS
(75:25 mol%) liposomes entrapping either the 0.5 kDa SulfoB (○) or the 70 kDa FITC-
dextran (●) were incubated with increasing concentrations of protein VI. The liposome
entrapped dye was then separated from the released dye by centrifugation and the
released dye quantiﬁed by ﬂuorescence spectroscopy as described in the Materials and
methods. Determination of maximal dye release was achieved using Triton X-100. Error
bars represent the standard error of the mean for a minimum of 3 replicates.
16 Rapid Communicationfragments lipid membranes observed by negative stain TEM (Wieth-
off et al., 2005). However, since negative stain TEM involves
substantial dehydration of lipid membranes leading to potentially
artifactual structures, our current results employing fully hydrated
membranes in which only the lipid membranes and not potential
protein aggregates are visualized provides greater conﬁdence in the
observation that pVI fragments membranes. Additionally, examina-
tion of pVI membrane lysis in solution has allowed us to visualize
novel tubular structures possessing highly curved surfaces not
previously observed by TEM. Although the biological signiﬁcance of
these tubules formed in the presence of pVI remain to be determined,
overexpression of pVI in cells demonstrates that pVI associates with
intracellular membranes, some of which appear to be part of a tubular
endocytic network (Wodrich et al., 2010).
Numerous membrane lytic proteins and peptides exist in nature.
These peptides often lyse membranes by induction of signiﬁcant
curvature stress. The amphipathic helix of pVI possesses a conserved
primary sequence found in many membrane associated proteinswhich correlates with their association with positively curved
membrane surfaces (Drin et al., 2007). Our data demonstrate that
pVI membrane lytic activity is enhanced by membranes with an
increased propensity to form positively curved membranes and is
decreased for membranes with a greater propensity to adopt
negatively curved structures. Thus, these observations along with
observed association of pVI with highly curvedmembranes supports a
model in which pVI lyses membranes by inducing positive curvature
in target membranes. Parvoviral capsids deploy a phospholipase A2
enzyme which hydrolyzes phospholipids to release the positive
curvature inducing lysolipids, although a role for curvature stress
has yet to be reported for parvoviral escape from endosomes (Zadori
et al., 2001; Farr et al., 2005; Lupescu et al., 2006). Furthermore, the
ﬂock house virus gamma peptide also induces membrane leakage but
does not induce membrane fusion (Maia et al., 2006), an activity
thought to rely on induction of negative curvature (Epand and Epand,
2000; Bertocco et al., 2003).
As a whole, our data shed new light into the mechanisms of
membrane disruption by a nonenveloped virus. Adenoviruses appear
to possess a novel method for disrupting endosomal membranes
during cell entry compared to those previously described for
17Rapid Communicationreoviruses, picornaviruses or parvoviruses. Of the above mentioned
nonenveloped viruses, adenovirus is best known for eliciting a
proinﬂammatory response during cell entry. In fact, much of this
inﬂammatory response is linked to the penetration of endosomal
membranes (Muruve, 2004; Zhu et al., 2007; Appledorn et al., 2008;
Fejer et al., 2008). Recent observations link the proinﬂammatory
response to certain intracellular bacteria with the membrane
fragments generated during phagosomal escape (Dupont et al.,
2009). While in vitro observations suggest that pVI fragments
membranes, it is unclear whethermembrane fragments are generated
by adenovirus during cell entry. Further work is required to determine
whether this proposed mechanism of adenovirus rupture of endoso-
mal membranes contributes to the proinﬂammatory response.
Materials and methods
Materials
1-Palmitoyl,2-oleoylphosphatidylcholine (POPC), 1-palmi-
toyl,2-oleoylphosphatidylserine (POPS), 1-palmitoyl,2-oleoyl-
phosphatidylethanolamine (POPE), 1-palmitoyl-2-stearoyl(6′,7′-
dibromo)-snglycero-3-phosphocholine 1-palmitoyl-2-stearoyl
(9′,10′-dibromo)-sn-glycero-3-phosphocholine and 1-palmitoyl-2-
stearoyl(11′,12′-dibromo)-sn-glycero-3-phosphocholine were
purchased from Avanti Polar Lipids. Saporin and α-Lysophosphati-
dylcholine (lysoPC) were from Sigma, and N-ﬂuoresceinyl-1, 2-sn-
dihexadecylphosphatidylethanolamine (FITC-DHPE) sulforhodamine
B, propidium iodide and alexaﬂuor488-dextran were obtained from
Invitrogen. All other reagents were from FisherBiotech. An E1, E3-
deleted human adenovirus 5 containing a CMV-driven EGFP reporter
gene was described previously (Wiethoff et al., 2005). HEK293 and
Hela cells were obtained from ATCC.
Generating pVI single tryptophan mutants
To generate pVI containing single tryptophan residues, mutations
were introduced in pET15bVI-N, a construct encoding residues 34–
114. This region of pVI has only 3 tryptophans, therefore to obtain
single tryptophan mutants, 2 out of the 3 tryptophan residues were
mutated to phenylalanine using the QuickChange II site-directed
mutagenesis kit (Strategene, La Jolla, CA). Three different mutants
were generated using the following primers. Complementary primers
are not shown. Altered nucleotides are indicated in bold.
W37 (W41/59F): VIW59F 5′ GGCAGCAAGGCCTTTAACAGCAGCA-
CAGG 3′
VIW41F 5′ GCTGGGGCTCGCTGTTTAGCGGCATTAAAAATTTCG 3′
W41 (W37/59F): VIW59F 5′ GGCAGCAAGGCCTTTAACAGCAGCA-
CAGG 3′
VIW37F 5′ ACAAGGCCTTCAGCTTTGGCTCGCTGTGGAGC 3′
W59 (W37/41F):VIW3741F 5′ GCTTTGGCTCGCTGTTTAGCGGCAT-
TAAAAATTTCG 3′
The mutations were conﬁrmed by sequencing, and the plasmids
were used to overexpress proteins in E. coli.
Puriﬁcation of recombinant proteins
Recombinant proteins were expressed in BL21(DE3) cells. Cultures
inoculated with overnight culture were grown at 37 °C, until they
reached an optical density at 600 nmof 1.0. TheNaCl concentrationwas
then increased by adding an additional 0.9 g NaCl/L, and protein
expression was induced by adding 1 mM IPTG (isopropyl-α-D-thioga-
lactopyranoside) for 1 h. Cells were pelleted, resuspended in cell lysis
buffer (1% Triton X-100, 25 mM phosphate, 150 mM NaCl pH 7.5,
0.5 mg/ml lysozyme, 0.1 mg/ml DNAse and 1 mM PMSF (phenyl-methylsulfonyl ﬂuoride)), and soluble protein was isolated by centri-
fugation at 13,000×g for 15 min at 4 °C. Recombinant proteins were
puriﬁed with Talon cobalt resin using the manufacturer's protocol (BD
Biosciences). Proteinswere extensively dialyzed into 25 mMPhosphate,
150 mM NaCl, and 10% (v/v) glycerol pH 7.5 before ﬂash freezing in
liquid nitrogen. Aliquots were stored at−80 °C until use.
Antibody inhibition of Ad membrane lytic activity
Rabbit polyclonal antiserum raised against puriﬁed preprotein VI
was obtained with appropriate institutional IACUC approval. IgG from
preimmune serumwas puriﬁed by protein G chromatography. Afﬁnity-
puriﬁed anti-pVI antibodies (αpVI) were obtained by chromatography
using puriﬁedproteinVI coupled to cyanogenbromide sepharose beads.
The ability of αpVI to prevent protein VI membrane permeabilization
was examined by incubating Hela cells with 25 μg/ml puriﬁed protein
VI in the presence or absence of 1 mg/ml preimmune IgG or αpVI at
37 °C. The efﬁciency of protein VI membrane permeabilization was
determined by using ﬂuorescence microscopy to measure the percent-
age of cells which took up the ﬂuorescent membrane impermeable
nuclear stain, propidium iodide, 30 min after protein addition.
Antibody inhibition of Ad infectivity and endosomal membrane
penetration
To determine the ability of αpVI to prevent Ad5 infection, Hela
cells were preincubated with varying concentrations of preimmune
IgG or αpVI for 6 h at 37 °C to saturate the endolysosomal system
prior to infection with Ad5gfp (1 gfp-transducing unit per cell) in the
continued presence of antibody. The percentage of gfp positive cells
was determined by ﬂuorescence microscopy 24 h post-infection.
To determine whether αpVI prevents Ad5 endosomal escape, Hela
cells were preincubated with 1 mg/ml of preimmune IgG or αpVI for
6 h at 37 °C to saturate the endolysosomal system prior to infection
with increasing MOIs of Ad5gfp in the presence of 0.05 mg/ml of the
membrane impermeable ribosomal toxin, saporin (Sigma) and in the
continued presence of antibody. Saporin dependent cell death in the
presence of increasing concentrations of Ad5gfp was compared to that
of saporin alone 24 h post-infection using an MTT assay for cell
viability. Data are presented as % cell viability compared to saporin
alone.
Determining pVI in vitro membrane lytic activity
Liposomes containing POPC:POPS (75:25 mol%), and entrapped
100 mMsulforhodamine B (SulfoB) (Molecular Probes)were generated
as previously described (Wiethoff et al., 2005). Liposomes containing
entrapped SulfoB were separated from free dye using a Sephadex G-75
column, preequilibratedwith25 mMHEPES, 150 mMNaCl bufferpH7.5
(HBS). The liposome concentration was determined using a phosphate
assay as previously described (Fiske and Subbarrow, 1925).
Membrane lytic activity of recombinant pVI was determined by
measuring SulfoB ﬂuorescence dequenching upon release from
liposomes. The liposomes were diluted in HBS to a ﬁnal concentration
of 10 μM. Different concentrations of pVI were then added to the
liposomes and incubated for 20 min at 37 °C. Fluorescence intensity
was measured using the Cary Eclipse ﬂuorescence spectrophotometer
(Varian) with the excitation wavelength of 575 nm and emission
wavelength of 590 nm. One hundred percent dye release was
determined by adding Triton X-100 to the liposomes at a ﬁnal
concentration of 0.5% (w/v). The percentage of SulfoB released was
calculated using the formula % SulfoB released=100×[Fmeas−F0)/
(Ftx100−F0)], where Fmeas is the maximum ﬂuorescence intensity
measured, F0 is ﬂuorescence intensity in absence of protein, and Ftx100
is the ﬂuorescence intensity in the presence of 0.5% Triton X-100.
18 Rapid CommunicationAnalysis of pVI binding to membranes
Protein VI contains 4 tryptophans at residues 37, 41, 59 and 229.
Binding to liposomes was assessed by monitoring changes in pVI
intrinsic tryptophan ﬂuorescence upon titration with increasing
amounts of liposomes (POPC:POPS 75:25 mol%). This approach is
routinely used for monitoring interactions between proteins and
ligands, membranes or other proteins and relies on the assumption
that the fractional spectral change in tryptophan ﬂuorescence
correlates directly with the amount of protein bound to its substrate
(Eftink, 1997). The ﬂuorescence emission spectra from 300–480 nm of
pVI in HBS and 37 °C was obtained by selective excitation of
tryptophan at 295 nm. Increasing amounts of liposomes were added
to pVI with mixing for 3 min and additional spectra were obtained.
Spectra of buffer or an equivalent amount of liposomes alone were
subtracted from the spectra of each protein/lipid mixture to obtain
corrected spectra. The spectral center of mass, Iλ, for the emission
spectra were determined using the Carey Eclipse software. Assuming
that this spectral change in tryptophan ﬂuorescence correlates with
the amount of protein bound, the fractional saturation of binding sites,
θ, was calculated using the following equation: θ=(Iλ(obs)− Iλ(0))/
(Iλ(max)− Iλ(0)), where Iλ(obs) is the spectral center of mass for each
protein/lipid ratio and Iλ(0) and Iλ(max) is the spectral center of mass
for protein alone and the protein in the presence of saturating
amounts of liposomes, respectively. Plotting θ versus protein/lipid
molar ratios yielded the resulting binding isotherms.
Analysis of pVI membrane penetration using Giant Lipid Vesicles (GLV)
GLV were generated as described previously (Akashi et al., 1996),
by mixing POPC, POPS and FITC-DHPE at a 70:25:5 mol ratio in
chloroform. A thin lipid ﬁlm was then generated on a glass tube by
evaporating the chloroform with a stream of nitrogen gas. Residual
chloroform was removed by placing the tube under vacuum for 6 h.
The lipid ﬁlm was then prehydrated with a stream of water saturated
nitrogen gas for 25 min, followed by rehydration in 6 ml of HBS
containing 0.1 M sucrose. The tube was then sealed with paraﬁlm and
incubated overnight at 37 °C. GLVs were harvested as a ﬂocculate near
the top of the solution the next day and quantiﬁed by phosphate assay
as described above. Typical preparations of GLVs are polydisperse
with vesicle diameters ranging from 5 to 50 μm. To visualize pVI
membrane lytic activity, recombinant pVIwas incubatedwith GLV at a
1:100 (lipid:protein) ratio in HBS with 0.1 M glucose, on a glass slide.
After 15 min the samples were analyzed by using an epiﬂuorescence
microscope.
Determining tryptophan depth of membrane penetration
Quenching of tryptophan ﬂuorescence by brominated phospholi-
pids was used to determine the depth of tryptophan penetration into
the lipid bilayer (Chattopadhyay and London, 1987; Ladokhin, 1997).
Liposomes containing 25 mol% POPS, 25 mol% POPC and 50 mol%
brominated phosphatidylcholine (Br2-PC) were made as described
above. Recombinant pVI single tryptophan mutants were incubated
for 10 min at 37 °C with brominated liposomes at a 1:100 (protein:
lipid) ratio in HBS pH 7.5. The intensity of tryptophan ﬂuorescence
was measured at 325 nm upon excitation at 295 nm. The differences
in quenching tryptophan ﬂuorescence by the (6,7)-, (9,10)-, (11,12)-
Br2-PC was used to calculate the location of the residue in the bilayer
using two methods: the parallax method (Chattopadhyay and
London, 1987) and distribution analysis (Ladokhin, 1997). In the
parallax method, the depth of the tryptophan residue was calculated
using the formula:
Zcf = Lcl + − ln F1 = F2ð Þ = πC–L221
 i
= 2L21
hwhere Zcf represents the distance of the ﬂuorophore from the center
of the bilayer, Lcl is the distance of the shallow quencher from the
center of the bilayer, Lcl is the distance between the shallow and deep
quencher, F1 is the ﬂuorescence intensity in the presence of the
shallow quencher, F2 is the ﬂuorescence intensity in the presence of
the deep quencher, and C is the concentration of quencher in
molecules/Å2. In the distribution analysis the depth of tryptophan
residue was calculated by ﬁtting the data to the equation:
ln F0 = Fhð Þ × c hð Þ = S = σ 2πð Þ1=2
h i
× exp − h−hmð Þ2 = 2σ2
h i
where F0 represents the ﬂuorescence intensity in the absence of the
brominated phospholipids, Fh is the intensity measured as a function of
the distance from the center of the lipid bilayer to the quencher h, c(h) is
the concentration of the different quenchers, S is the area under the
curve (measurement of quenching efﬁciency), σ is the dispersion (a
measure of the distribution of the depth in the bilayer), hm is the most
probable position of the ﬂuorophore in the membrane, and h is the
average brominedistances from the center of the bilayer, basedonX-ray
diffraction and taken to be 10.8, 8.3, and 6.3 Å for (6,7)-, (9,10)- and
(11,12)-Br2-PC respectively.When equal concentrations of the Br-lipids
are used, the c(h) value is unity.
Acknowledgments
We would like to acknowledge funding from the NIH to C.M.W
(AI082430), and a subcontract from HL054352 (awarded to Glen R.
Nemerow), and O.M. (AI007508). H.W. acknowledges ﬁnancial support
from a CNRS idea grant (PEPS 2009) and support from the Aquitaine
region.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.virol.2010.03.043.
References
Akashi, K., Miyata, H., et al., 1996. Preparation of giant liposomes in physiological
conditions and their characterization under an optical microscope. Biophys. J. 71
(6), 3242–3250.
Appledorn, D.M., Patial, S., et al., 2008. Adenovirus vector-induced innate inﬂammatory
mediators, MAPK signaling, as well as adaptive immune responses are dependent
upon both TLR2 and TLR9 in vivo. J. Immunol. 181 (3), 2134–2144.
Banerjee, M., Khayat, R., et al., 2009. Dissecting the functional domains of a
nonenveloped virus membrane penetration peptide. J. Virol. 83 (13), 6929–6933.
Bertocco, A., Formaggio, F., et al., 2003. Design and function of a conformationally
restricted analog of the inﬂuenza virus fusion peptide. J. Pept. Res. 62 (1), 19–26.
Bohrer, M.P., Deen, W.M., et al., 1979. Inﬂuence of molecular conﬁguration on the
passage of macromolecules across the glomerular capillary wall. J. Gen. Physiol. 74
(5), 583–593.
Bong, D.T., Janshoff, A., et al., 2000. Membrane partitioning of the cleavage peptide in
ﬂock house virus. Biophys. J. 78 (2), 839–845.
Brogden, K.A., 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in
bacteria? Nat. Rev. Microbiol. 3 (3), 238–250.
Brown, D.T., Burlingham, B.T., 1973. Penetration of host cell membranes by adenovirus
2. J. Virol. 12 (2), 386–396.
Chattopadhyay, A., London, E., 1987. Parallax method for direct measurement of
membrane penetration depth utilizing ﬂuorescence quenching by spin-labeled
phospholipids. Biochemistry 26 (1), 39–45.
Chroboczek, J., Ruigrok, R.W., et al., 1995. Adenovirus ﬁber. Curr. Top. Microbiol.
Immunol. 199 (Pt 1), 163–200.
Danthi, P., Coffey, C.M., et al., 2008a. Independent regulation of reovirus membrane
penetration and apoptosis by the mu1 phi domain. PLoS Pathog. 4 (12), e1000248.
Danthi, P., Kobayashi, T., et al., 2008b. Reovirus apoptosis and virulence are regulated by
host cell membrane penetration efﬁciency. J. Virol. 82 (1), 161–172.
Ding, J., McGrath, W.J., et al., 1996. Crystal structure of the human adenovirus
proteinase with its 11 amino acid cofactor. Embo J. 15 (8), 1778–1783.
Dowling, W., Denisova, E., et al., 2000. Selective membrane permeabilization by the
rotavirus VP5* protein is abrogated by mutations in an internal hydrophobic
domain. J. Virol. 74 (14), 6368–6376.
Drin, G., Casella, J.F., et al., 2007. A general amphipathic alpha-helical motif for sensing
membrane curvature. Nat. Struct. Mol. Biol. 14 (2), 138–146.
19Rapid CommunicationDupont,N., Lacas-Gervais, S., et al., 2009. Shigellaphagocytic vacuolarmembrane remnants
participate in the cellular response to pathogen invasion and are regulated by
autophagy. Cell Host Microbe 6 (2), 137–149.
Eftink, M.R., 1997. Fluorescence methods for studying equilibrium macromolecule–
ligand interactions. Methods Enzymol. 278, 221–257.
Epand, R.M., Epand, R.F., 2000. Modulation of membrane curvature by peptides.
Biopolymers 55 (5), 358–363.
Epand, R.M., Vogel, H.J., 1999. Diversity of antimicrobial peptides and their mechanisms
of action. Biochim. Biophys. Acta 1462 (1–2), 11–28.
Everitt, E., Lutter, L., et al., 1975. Structural proteins of adenoviruses. XII. Location and
neighbor relationship among proteins of adenovirion type 2 as revealed by
enzymatic iodination, immunoprecipitation and chemical cross-linking. Virology
67 (1), 197–208.
Farr, G.A., Zhang, L.G., et al., 2005. Parvoviral virions deploy a capsid-tethered lipolytic
enzyme to breach the endosomal membrane during cell entry. Proc. Natl. Acad. Sci.
U. S. A. 102 (47), 17148–17153.
Fejer, G., Drechsel, L., et al., 2008. Key role of splenic myeloid DCs in the IFN-alphabeta
response to adenoviruses in vivo. PLoS Pathog. 4 (11), e1000208.
Fiske, C.H., Subbarrow, Y., 1925. The colorimetric determination of phosphorous. J. Biol.
Chem. 66, 374–389.
Ghosh, A.K., Rukmini, R., et al., 1997. Modulation of tryptophan environment in
membrane-bound melittin by negatively charged phospholipids: implications in
membrane organization and function. Biochemistry 36 (47), 14291–14305.
Golantsova, N.E., Gorbunova, E.E., et al., 2004. Discrete domains within the rotavirus
VP5* direct peripheral membrane association and membrane permeability. J. Virol.
78 (4), 2037–2044.
Greber, U.F., Willetts, M., et al., 1993. Stepwise dismantling of adenovirus 2 during entry
into cells. Cell 75 (3), 477–486.
Greber, U.F., Webster, P., et al., 1996. The role of the adenovirus protease on virus entry
into cells. Embo J. 15 (8), 1766–1777.
Hannan, C., Raptis, L.H., et al., 1983. Biological and structural studies with an adenovirus
type 2 temperature-sensitive mutant defective for uncoating. Intervirology 19 (4),
213–223.
Hooper, J.W., Fields, B.N., 1996. Monoclonal antibodies to reovirus sigma 1 and mu 1
proteins inhibit chromium release from mouse L cells. J. Virol. 70 (1), 672–677.
Ivanovic, T., Agosto, M.A., et al., 2008. Peptides released from reovirus outer capsid form
membrane pores that recruit virus particles. Embo J. 27 (8), 1289–1298.
Kamper, N., Day, P.M., et al., 2006. A membrane-destabilizing peptide in capsid protein
L2 is required for egress of papillomavirus genomes from endosomes. J. Virol. 80
(2), 759–768.
Ladokhin, A.S., 1997. Distribution analysis of depth-dependent ﬂuorescence quenching
in membranes: a practical guide. Methods Enzymol. 278, 462–473.
Ladokhin, A.S., Selsted, M.E., et al., 1997. Sizing membrane pores in lipid vesicles by
leakage of co-encapsulated markers: pore formation by melittin. Biophys. J. 72 (4),
1762–1766.
Lehmberg, E., Traina, J.A., et al., 1999. Reversed-phase high-performance liquid
chromatographic assay for the adenovirus type 5 proteome. J. Chromatogr. B
Biomed. Sci. Appl. 732 (2), 411–423.
Li, Q., Yafal, A.G., et al., 1994. Poliovirus neutralization by antibodies to internal epitopes
of VP4 and VP1 results from reversible exposure of these sequences at physiological
temperature. J. Virol. 68 (6), 3965–3970.
Lupescu, A., Bock, C.T., et al., 2006. Phospholipase A2 activity-dependent stimulation
of Ca2+ entry by human parvovirus B19 capsid protein VP1. J. Virol. 80 (22),
11370–11380.
Maia, L.F., Soares, M.R., et al., 2006. Structure of a membrane-binding domain from a
non-enveloped animal virus: insights into the mechanism of membrane perme-
ability and cellular entry. J. Biol. Chem. 281 (39), 29278–29286.
Mangel, W.F., Toledo, D.L., et al., 1996. Characterization of three components of human
adenovirus proteinase activity in vitro. J. Biol. Chem. 271 (1), 536–543.
Markello, T., Zlotnick, A., et al., 1985. Determination of the topography of
cytochrome b5 in lipid vesicles by ﬂuorescence quenching. Biochemistry 24
(12), 2895–2901.
Matthews, D.A., Russell, W.C., 1994. Adenovirus protein–protein interactions: hexon
and protein VI. J. Gen. Virol. 75 (Pt 12), 3365–3374.
Matthews, D.A., Russell, W.C., 1995. Adenovirus protein–protein interactions: molec-
ular parameters governing the binding of protein VI to hexon and the activation of
the adenovirus 23 K protease. J. Gen. Virol. 76 (Pt 8), 1959–1969.Muruve, D.A., 2004. The innate immune response to adenovirus vectors. Hum. Gene
Ther. 15 (12), 1157–1166.
Nakano, M.Y., Boucke, K., et al., 2000. The ﬁrst step of adenovirus type 2 disassembly
occurs at the cell surface, independently of endocytosis and escape to the cytosol.
J. Virol. 74 (15), 7085–7095.
Nemerow, G.R., 2000. Cell receptors involved in adenovirus entry. Virology 274 (1),
1–4.
Prchla, E., Plank, C., et al., 1995. Virus-mediated release of endosomal content in vitro:
different behavior of adenovirus and rhinovirus serotype 2. J. Cell Biol. 131 (1),
111–123.
Roelvink, P.W., Lizonova, A., et al., 1998. The coxsackievirus–adenovirus receptor
protein can function as a cellular attachment protein for adenovirus serotypes from
subgroups A, C, D, E, and F. J. Virol. 72 (10), 7909–7915.
Saban, S.D., Nepomuceno, R.R., et al., 2005. CryoEM structure at 9 A resolution of an
adenovirus vector targeted to hematopoietic cells. J. Mol. Biol. 349 (3), 526–537.
Saban, S.D., Silvestry, M., et al., 2006. Visualization of alpha-helices in a 6-angstrom
resolution cryoelectron microscopy structure of adenovirus allows reﬁnement of
capsid protein assignments. J. Virol. 80 (24), 12049–12059.
Sakurai, F., Kawabata, K., et al., 2007. Adenovirus vectors composed of subgroup B
adenoviruses. Curr. Gene Ther. 7 (4), 229–238.
Seth, P., 1994. Adenovirus-dependent release of choline from plasma membrane vesicles
at an acidic pH is mediated by the penton base protein. J. Virol. 68 (2), 1204–1206.
Seth, P., Fitzgerald, D., et al., 1984. Evidence that the penton base of adenovirus is
involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to
epidermal growth factor. Mol. Cell. Biol. 4 (8), 1528–1533.
Seth, P., Willingham,M.C., et al., 1985. Binding of adenovirus and its external proteins to
Triton X-114. Dependence on pH. J. Biol. Chem. 260 (27), 14431–14434.
Silvestry, M., Lindert, S., et al., 2009. Cryoelectron microscopy structure of the adenovirus
type 2 temperature sensitivemutant 1 reveals insight into the cell entry defect. J. Virol.
83 (15), 7375–7383.
Smith, J.G., Nemerow, G.R., 2008. Mechanism of adenovirus neutralization by human
alpha-defensins. Cell Host Microbe 3 (1), 11–19.
Stewart, P.L., Fuller, S.D., et al., 1993. Difference imaging of adenovirus: bridging the
resolution gap between X-ray crystallography and electron microscopy. Embo J. 12
(7), 2589–2599.
Svensson, U., 1985. Role of vesicles during adenovirus 2 internalization into HeLa cells.
J. Virol. 55 (2), 442–449.
Svensson, U., Persson, R., 1984. Entry of adenovirus 2 into HeLa cells. J. Virol. 51 (3),
687–694.
Tihova, M., Dryden, K.A., et al., 2001. Localization of membrane permeabilization and
receptor binding sites on the VP4 hemagglutinin of rotavirus: implications for cell
entry. J. Mol. Biol. 314 (5), 985–992.
Tosteson, M.T., Chow, M., 1997. Characterization of the ion channels formed by
poliovirus in planar lipid membranes. J. Virol. 71 (1), 507–511.
Tsai, B., 2007. Penetration of nonenveloped viruses into the cytoplasm. Annu. Rev. Cell
Dev. Biol. 23, 23–43.
van Oostrum, J., Burnett, R.M., 1985. Molecular composition of the adenovirus type 2
virion. J. Virol. 56 (2), 439–448.
Webster, A., Kemp, G., 1993. The active adenovirus protease is the intact L3 23K protein.
J. Gen. Virol. 74 (Pt 7), 1415–1420.
Wickham, T.J., Mathias, P., et al., 1993. Integrins alpha v beta 3 and alpha v beta 5
promote adenovirus internalization but not virus attachment. Cell 73 (2), 309–319.
Wickham, T.J., Filardo, E.J., et al., 1994. Integrin alpha v beta 5 selectively promotes
adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127 (1), 257–264.
Wiethoff, C.M., Wodrich, H., et al., 2005. Adenovirus protein VI mediates membrane
disruption following capsid disassembly. J. Virol. 79 (4), 1992–2000.
Wimley, W.C., White, S.H., 1996. Experimentally determined hydrophobicity scale for
proteins at membrane interfaces. Nat. Struct. Biol. 3 (10), 842–848.
Wodrich, H., Guan, T., et al., 2003. Switch from capsid protein import to adenovirus
assembly by cleavage of nuclear transport signals. Embo J. 22 (23), 6245–6255.
Wodrich, H., Henaff, D., et al., 2010. A capsid-encoded PPxY-motif facilitates adenovirus
entry. PLoS Pathog. 6 (3), e1000808.
Zadori, Z., Szelei, J., et al., 2001. A viral phospholipase A2 is required for parvovirus
infectivity. Dev. Cell 1 (2), 291–302.
Zhu, J., Huang, X., et al., 2007. Innate immuneresponse to adenoviral vectors ismediatedby
both Toll-like receptor-dependent and -independent pathways. J. Virol. 81 (7),
3170–3180.
